|Bid||17.98 x 300|
|Ask||17.99 x 400|
|Day's Range||17.82 - 18.47|
|52 Week Range||5.85 - 18.54|
|PE Ratio (TTM)||89.55|
|Earnings Date||Oct 30, 2017 - Nov 3, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||15.40|
Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy products.
Here's a trio of companies that have risen by 100% or more so far in 2017.
In focus: Abeona Therapeutics, Corcept Therapeutics, ImmunoGen and Sangamo Therapeutics.